Non-Coding RNAs in Glioma

Area of Science:

• Neuro-oncology
• Molecular Biology
• Genomics

Background:

• Glioma, a highly aggressive central nervous system tumor, is characterized by cellular migration, proliferation, and heterogeneity, leading to poor patient survival.
• Non-coding RNAs (ncRNAs) are increasingly recognized for their regulatory roles in glioma initiation and progression.
• Recent findings emphasize the cross-regulation between long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in driving glioblastoma subclass diversity.

Purpose of the Study:

• To review the expression of long non-coding RNAs in human glioma tissues over a five-year period.
• To summarize the current understanding of ncRNAs in glioblastoma pathogenesis.
• To explore the potential of ncRNAs in glioma grading and as biomarkers.

Main Methods:

• Literature review of studies evaluating long non-coding RNA expression in human glioma tissues.
• Analysis of data on the role of ncRNAs in glioblastoma pathogenesis.
• Synthesis of information regarding the interplay between lncRNAs and miRNAs.

Main Results:

• Non-coding RNAs are integral to the biological processes governing glioma.
• The cross-regulation between lncRNAs and miRNAs contributes to glioblastoma heterogeneity.
• Expression data from human glioma tissues over five years provide insights into ncRNA roles.

Conclusions:

• Non-coding RNAs are critical players in glioblastoma pathogenesis.
• ncRNAs show promise for application in glioma grading and as diagnostic biomarkers.
• Understanding lncRNA-miRNA crosstalk is essential for future therapeutic strategies.